Skip to main content
Thomas Rothstein, MD, Oncology, Roxbury, MA

ThomasL.RothsteinMDPhD

Oncology • Roxbury, MA

Investigator and Head, Center for Oncology and Cell Biology, Feinstein Institute for Medical Research; Professor of Medicine and Professor of Molecular Medicine, Hofstra North Shore-LIJ School of Medicine

Join to view full profile

Dr. Rothstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rothstein's full profile

Already have an account?

  • Office

    Boston Medical Center
    650 Albany Stebr C 437
    Roxbury, MA 02118
    Phone+1 617-638-7028
    Fax+1 516-562-2533

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1977 - 1979
  • George Washington University
    George Washington UniversityInternship, Internal Medicine, 1974 - 1975
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2019
  • VA State Medical License
    VA State Medical License 1999 - 2018

Publications & Presentations

PubMed

Abstracts/Posters

  • Mutation of Murine Rpl5 reveals a New Model for Diamond Blackfan Anemia Characterized By Defective Erythropoiesis
    Thomas L. Rothstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Scientists Finally Have Evidence of Mysterious Immune Cell in Humans
    Scientists Finally Have Evidence of Mysterious Immune Cell in HumansMay 13th, 2022
  • Scientists Finally Have Proof of Mysterious Immune Cell in Humans
    Scientists Finally Have Proof of Mysterious Immune Cell in HumansMay 12th, 2022
  • Editorial: Natural Antibodies in Health and Disease
    Editorial: Natural Antibodies in Health and DiseaseDecember 13th, 2017

Grant Support

  • An Alternate Pathway To AutoimmunityNational Institute Of Allergy And Infectious Diseases2008–2012
  • FAIM In Immunity And AutoimmunityNational Institute Of Allergy And Infectious Diseases2010–2011
  • Aberrant Signaling In B-1 CellsNational Institute Of Allergy And Infectious Diseases2005–2011
  • B1 Cell Induction Of TH17 Cell DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2010
  • FAIM In Immunity And AutoimmunityNational Institute Of Allergy And Infectious Diseases2009
  • B-1 Cell Isolation And PurificationNational Institute Of Allergy And Infectious Diseases2008
  • B-1 Cell Differentiation And Immunoglobulin SecretionNational Institute Of Allergy And Infectious Diseases2008
  • Administration CoreNational Institute Of Allergy And Infectious Diseases2008
  • Aberrant Signaling In B-1 CellsNational Institute Of Allergy And Infectious Diseases2008
  • Molecular Determinants Of B-1 And B-2 Cell ResponsesNational Institute Of Allergy And Infectious Diseases2005–2008
  • Differentiation And Signaling In B-1 CellsNational Institute Of Allergy And Infectious Diseases2005–2007
  • Core--B-1 Cell Isolation And PurificationNational Institute Of Allergy And Infectious Diseases2005–2007
  • Regulation Of Fas-Mediated ApoptosisNational Institute Of Allergy And Infectious Diseases2006
  • Molecular Determinants Of B-1 And B-2 Cell ResponsesNational Institute Of Allergy And Infectious Diseases2004–2005
  • Differentiation And Signaling In B-1 CellsNational Institute Of Allergy And Infectious Diseases2004–2005
  • Core--B-1 Cell Isolation And PurificationNational Institute Of Allergy And Infectious Diseases2004–2005
  • Research Training In Blood Diseases And ResourcesNational Heart, Lung, And Blood Institute2003–2005
  • Regulation Of Fas-Mediated ApoptosisNational Institute Of Allergy And Infectious Diseases2002–2005
  • Aberrant Signaling In B-1 CellsNational Institute Of Allergy And Infectious Diseases1998–2005
  • A Novel FAS Apoptosis Inhibitory Molecule (FAIM)National Institute Of Allergy And Infectious Diseases2000–2003
  • Regulation Of Fas-Mediated ApoptosisNational Institute Of Allergy And Infectious Diseases2001
  • New Pathway For STAT ActivationNational Institute Of Allergy And Infectious Diseases1998–2000
  • Regulation Of Fas-Mediated Apoptosis In B CellsNational Institute Of Allergy And Infectious Diseases1996–1998
  • Regulation Of Nf-Kb And NF-AT Proteins In B LymphocytesNational Cancer Institute1995–1998
  • Aberrant Signaling In B1 CellsNational Institute Of Allergy And Infectious Diseases1997
  • Aberrant Signaling In B-1 LymphocytesNational Institute Of Allergy And Infectious Diseases1994–1996
  • B-Cell Stimulation Induced By CytochalasinNational Institute Of Allergy And Infectious Diseases1994
  • Aberrant Signaling In B-1 LymphocytesNational Institute Of Allergy And Infectious Diseases1993
  • Analysis Of B Cell Stimulation Induced By CytochalasinNational Institute Of Allergy And Infectious Diseases1986–1993
  • Phorbol Ester Responsive B LymphocytesNational Institute Of Allergy And Infectious Diseases1990–1992
  • Immunoregulation Of Human Malignant B LymphocytesNational Cancer Institute1988–1989
  • Immunoregulation Of Human Malignant By LymphocytesNational Cancer Institute1986–1987

Dr. Thomas Rothstein, Dr. Thomas Rothstein, MD, Dr. T Rothstein, Dr. Thomas L. Rothstein